| ID: | 139 | |
|---|---|---|
| Name: | Compound 139 | |
| Description: | Original numeration in publication: 6f | |
| Labels: | Training_set, Phthalazines | |
| CAS: | ||
| InChi Code: | InChI=1S/C29H23N5O/c1-20-11-13-21(14-12-20)19-30-34-29(35)23-15-17-24(18-16-23)31-28-26-10-6-5-9-25(26)27(32-33-28)22-7-3-2-4-8-22/h2-19H,1H3,(H,31,33)(H,34,35)/b30-19+ |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.06 |
El-Adl, K.; Ibrahim, M. K.; Khedr, F. a. A., H. S.; Eissa, I. H. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch. Pharm. (Weinheim) 2022, 355, e2100278. https://doi.org/10.1002/ardp.202100278 |
| 6.41463 |
Eq1: VEGFR-2 inhibition (Data used to train model) |